BillionToOne, Inc.
BLLN
Peringkat dalam Saham
#3441
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Harga Saham
$105.11
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$4.96B
Perubahan (1 hari)
1.56%
Perubahan (1 tahun)
-
Negara
US
Perdagangan BillionToOne, Inc. (BLLN)
Kategori
Healthcare
Riwayat harga saham BillionToOne, Inc. (BLLN)
Harga penutupan tertinggi: $100.39 pada 2026-10-01
Harga penutupan terendah: $106.24 pada 2025-11-01
Harga penutupan terendah: $106.24 pada 2025-11-01
Riwayat harga saham BillionToOne, Inc. dari 2025 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | -1.87% |
| 2025 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
